270 related articles for article (PubMed ID: 16829212)
1. Distinguishing primary and secondary translocations in multiple myeloma.
Gabrea A; Leif Bergsagel P; Michael Kuehl W
DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
[TBL] [Abstract][Full Text] [Related]
2. Chromosome translocations in multiple myeloma.
Bergsagel PL; Kuehl WM
Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
[TBL] [Abstract][Full Text] [Related]
3. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
Chesi M; Kuehl WM; Bergsagel PL
Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.
Shaughnessy J; Gabrea A; Qi Y; Brents L; Zhan F; Tian E; Sawyer J; Barlogie B; Bergsagel PL; Kuehl M
Blood; 2001 Jul; 98(1):217-23. PubMed ID: 11418483
[TBL] [Abstract][Full Text] [Related]
5. Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.
Gabrea A; Martelli ML; Qi Y; Roschke A; Barlogie B; Shaughnessy JD; Sawyer JR; Kuehl WM
Genes Chromosomes Cancer; 2008 Jul; 47(7):573-90. PubMed ID: 18381641
[TBL] [Abstract][Full Text] [Related]
6. Close relation between 14q32/IGH translocations and chromosome 13 abnormalities in multiple myeloma: a high incidence of 11q13/CCND1 and 16q23/MAF.
Takimoto M; Ogawa K; Kato Y; Saito T; Suzuki T; Irei M; Shibuya Y; Suzuki Y; Kato M; Inoue Y; Takahashi M; Sugimori H; Miura I
Int J Hematol; 2008 Apr; 87(3):260-5. PubMed ID: 18274833
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis and a consequent classification of multiple myeloma.
Bergsagel PL; Kuehl WM
J Clin Oncol; 2005 Sep; 23(26):6333-8. PubMed ID: 16155016
[TBL] [Abstract][Full Text] [Related]
8. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
[TBL] [Abstract][Full Text] [Related]
9. IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc.
Bergsagel PL; Nardini E; Brents L; Chesi M; Kuehl WM
Curr Top Microbiol Immunol; 1997; 224():283-7. PubMed ID: 9308253
[TBL] [Abstract][Full Text] [Related]
10. Myc translocations in B cell and plasma cell neoplasms.
Janz S
DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
[TBL] [Abstract][Full Text] [Related]
11. Early genetic events provide the basis for a clinical classification of multiple myeloma.
Kuehl WM; Bergsagel PL
Hematology Am Soc Hematol Educ Program; 2005; ():346-52. PubMed ID: 16304402
[TBL] [Abstract][Full Text] [Related]
12. [Molecular Mechanism and Malignant Clonal Evolution of Multiple Myeloma].
Ding F; Zhu P; Wu XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1513-6. PubMed ID: 26524068
[TBL] [Abstract][Full Text] [Related]
13. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
Bergsagel PL; Chesi M; Nardini E; Brents LA; Kirby SL; Kuehl WM
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13931-6. PubMed ID: 8943038
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.
Chesi M; Bergsagel PL; Brents LA; Smith CM; Gerhard DS; Kuehl WM
Blood; 1996 Jul; 88(2):674-81. PubMed ID: 8695815
[TBL] [Abstract][Full Text] [Related]
15. Characterization of MYC translocations in multiple myeloma cell lines.
Dib A; Gabrea A; Glebov OK; Bergsagel PL; Kuehl WM
J Natl Cancer Inst Monogr; 2008; (39):25-31. PubMed ID: 18647998
[TBL] [Abstract][Full Text] [Related]
16. Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma.
Bergsagel PL; Kuehl WM
Immunol Rev; 2003 Aug; 194():96-104. PubMed ID: 12846810
[TBL] [Abstract][Full Text] [Related]
17. Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma.
Burmeister T; Molkentin M; Schwartz S; Gökbuget N; Hoelzer D; Thiel E; Reinhardt R
Mol Oncol; 2013 Aug; 7(4):850-8. PubMed ID: 23673335
[TBL] [Abstract][Full Text] [Related]
18. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathogenesis of Multiple Myeloma: Clinical Implications.
Maura F; Bergsagel PL
Hematol Oncol Clin North Am; 2024 Apr; 38(2):267-279. PubMed ID: 38199896
[TBL] [Abstract][Full Text] [Related]
20. Advances in biology of multiple myeloma: clinical applications.
Hideshima T; Bergsagel PL; Kuehl WM; Anderson KC
Blood; 2004 Aug; 104(3):607-18. PubMed ID: 15090448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
